Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 142 -1.50 (-1.05%)
As of 03:48 AM Eastern

KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, DVRG, TRLS, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs. Its Competitors

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£66.34M0.77£4.00M£0.081,775.00
Instem£61.63M0.00£3.34M£0.14N/A

In the previous week, Instem had 1 more articles in the media than Kooth. MarketBeat recorded 1 mentions for Instem and 0 mentions for Kooth. Kooth's average media sentiment score of 0.00 equaled Instem'saverage media sentiment score.

Company Overall Sentiment
Kooth Neutral
Instem Neutral

26.4% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 30.7% of Kooth shares are owned by company insiders. Comparatively, 30.0% of Instem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Kooth currently has a consensus price target of GBX 365, indicating a potential upside of 157.04%. Given Kooth's stronger consensus rating and higher possible upside, analysts clearly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500.

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 18.59% 10.12%
Instem 5.50%6.35%4.62%

Summary

Kooth beats Instem on 10 of the 14 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£51.14M£369.90M£6.14B£2.61B
Dividend YieldN/A5.89%5.66%5.28%
P/E Ratio1,775.00526.3785.724,428.74
Price / Sales0.77249.51631.45100,208.37
Price / Cash5.4247.1438.3227.90
Price / Book2.205.1513.098.78
Net Income£4.00M-£15.55M£3.30B£5.89B
7 Day Performance-2.07%-0.11%3.75%0.45%
1 Month Performance-7.19%8.43%10.73%6.03%
1 Year Performance-50.71%14.49%85.28%152.69%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
N/AGBX 142
-1.0%
GBX 365
+157.0%
-50.9%£51.14M£66.34M1,775.00478
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
RENX
Renalytix
N/AGBX 8.99
-2.8%
N/A+15.8%£29.79M£2.37M-56.21102Gap Up
High Trading Volume
COG
Cambridge Cognition
N/AGBX 37.45
+1.2%
N/A+1.8%£17.21M£9.05M-985.5380
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/AN/A£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 10.60
+6.0%
N/A-71.4%£4.64M£1.19M-43.3724Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-38.5%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.71
-5.9%
N/A-2.8%£1.14M£114K-14.1231Gap Down
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners